Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway
- 1 August 2017
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 528 (1-2) , 163-171
Abstract
No abstract availableKeywords
Funding Information
- Beijing Natural Science Foundation of China (7154230)
This publication has 48 references indexed in Scilit:
- Prevalence of and outcomes from Staphylococcus aureus pneumonia among hospitalized patients in the United States, 2009-2012American Journal of Infection Control, 2017
- The uremic toxin methylguanidine increases the oxidative metabolism and accelerates the apoptosis of canine neutrophilsVeterinary Immunology and Immunopathology, 2017
- The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumoniaNature Communications, 2017
- Self-assemblies of 5′-cholesteryl-ethyl-phosphoryl zidovudineColloids and Surfaces B: Biointerfaces, 2016
- Evaluation of IFN-γ polymorphism+874 T/A in patients with recurrent tonsillitis by PCR Real Time Mismatch Amplification Mutation Assay (MAMA Real Time PCR)Cytokine, 2015
- Short communication: Prevalence and antibiotic resistance of Staphylococcus aureus isolated from bovine clinical mastitisJournal of Dairy Science, 2014
- Controlled Release Pulmonary Administration of Curcumin Using Swellable Biocompatible MicroparticlesMolecular Pharmaceutics, 2011
- Neutrophil Recruitment to the Lungs during Bacterial PneumoniaInfection and Immunity, 2009
- Severe Community-acquired Pneumonia Due toStaphylococcus aureus, 2003–04 Influenza SeasonEmerging Infectious Diseases, 2006
- Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin GenesClinical Infectious Diseases, 2005